Abstract: An application system is provided, which includes an application device configured to discharge a coating material from a discharge circuit; an articulated robot configured to change a position and an orientation of the discharge circuit such that the coating material from the discharge circuit is applied to a workpiece; and a control device configured to control the application device and the articulated robot, in which the control device includes a target value calculation circuit and an operation control circuit.

Abstract: A control system including a discharge control circuit configured to control an application device such that a coating is discharged from a discharge circuit; a robot control circuit configured to cause an articulated robot to change a position and an orientation of the discharge circuit such that the coating is applied to a workpiece; an application abnormality detection circuit configured to detect an abnormality in an application state of the coating on the basis of at least one of a state of the device or of the robot; an application position calculation circuit configured to calculate an application position of the coating; and an abnormality notification circuit configured to send a notification of a site of an abnormality in the application state on the workpiece on the basis of a detection result of the abnormality in the application state and a calculation result of the application position.

Abstract: One aspect of the ink jet ink set according to the present disclosure is an ink jet ink set including an anionic ink containing an anionic resin, a pigment, and water, and a cationic ink containing a cationic resin, a pigment, and water, in which the anionic ink and the cationic ink are similar colors to each other, the pigment in the anionic ink is coated with the anionic resin, the pigment in the cationic ink is coated with the cationic resin, and the anionic resin or the cationic resin, or both have a urethane-based skeleton or a polyester-based skeleton.

Abstract: Provided is a conveyance seat in which a duct connected to a fan can be compactly disposed, and the fan is provided in a pan-frame-type seat cushion. The vehicle seat includes a seat cushion (S2) and a blower (48) provided in the seat cushion (S2). The seat cushion (S2) is provided with a plate-shaped pan frame (42). The blower (48) is provided below the pan frame (42), a duct (49) is connected to the blower (48), and an opening (42a) through which the duct (49) extends is formed in the pan frame (42).

Abstract: An aqueous suspension preparation that comprises a macrolide antibacterial agent as an active component. The aqueous suspension preparation is characterized by comprising nanoparticles of a macrolide antibacterial agent and a dispersion stabilizer; an aqueous suspension in which the average particle size of nanoparticles is 500 nm or less and the D90 particle size is 1,500 nm or less; a parenterally administered pharmaceutical composition that comprises this aqueous suspension preparation; an injection preparation; and eye drops or ear drops, more specifically, eye drops for the treatment or prevention of inflammatory diseases of the eye or ear drops for the treatment or prevention of inflammatory diseases of the ear.

Abstract: An aqueous ink jet composition of the present disclosure includes: at least one dye selected from the group consisting of C.I. Solvent Yellow 160:1, C.I. Disperse Yellow 82, and C.I. Disperse Yellow 184; a material A which is at least one compound selected from the group consisting of a compound represented by the following formula (1), a compound represented by the following formula (2), an ethylene oxide adduct of tristyrylphenol, a derivative of an ethylene oxide adduct of tristyrylphenol, a polyalkylene glycol, and a derivative of a polyalkylene glycol; and an anionic dispersant.

Abstract: An aqueous ink jet composition contains: C.I. Disperse Red 364; a material A which is at least one compound selected from the group consisting of a compound represented by the following formula (1), a compound represented by the following formula (2), an ethylene oxide adduct of tristyrylphenol, a derivative of the ethylene oxide adduct of tristyrylphenol, a polyalkylene glycol, and a derivative of the polyalkylene glycol; and an anionic dispersant.

Abstract: A method of treating an inflammatory or infectious disease includes administering an effective amount of pharmaceutical composition to a subject in need of treatment of the inflammatory or infectious disease. The composition includes an aqueous suspension of nanoparticles of a glucocorticosteroid compound.

Abstract: An aqueous suspension containing as an active component a glucocorticosteroid compound is described. The aqueous suspension contains nanoparticles of a glucocorticosteroid compound and a dispersion stabilizer. The nanoparticles have a mean particle diameter of 300 nm or less and a D90 particle diameter of 450 nm or less. The pharmaceutical compositions containing the aqueous suspension are for parenteral administrations, injections, eye drops or ear drops. More specifically the aqueous suspensions containing glucocorticosteroid nanoparticles are used as an eye drop for treating or preventing inflammatory diseases of the eye or an ear drop for treating or preventing inflammatory diseases of the ear.

Abstract: Provided is a conveyance seat in which a duct connected to a fan can be compactly disposed, and the fan is provided in a pan-frame-type seat cushion. The vehicle seat includes a seat cushion (S2) and a blower (48) provided in the seat cushion (S2). The seat cushion (S2) is provided with a plate-shaped pan frame (42). The blower (48) is provided below the pan frame (42), a duct (49) is connected to the blower (48), and an opening (42a) through which the duct (49) extends is formed in the pan frame (42).

Abstract: An aqueous ink jet composition includes a first component which is at least one selected from the group consisting of C.I. Solvent Yellow 160: 1, C.I. Disperse Yellow 82, and C.I. Disperse Yellow 184; a second component which is a dispersant having at least one chemical structure of a sulfo group and a salt thereof; and a third component which has a cumarin skeleton and at least one chemical structure of a sulfo group and a salt thereof.

Abstract: An aqueous inkjet composition contains at least one disperse dye selected from the group consisting of C.I. Disperse Yellow 54, C.I. Disperse Red 60, and C.I. Disperse Blue 359, and a styrene maleic acid-based dispersing agent represented by Formula (1).

Abstract: An aqueous suspension containing as an active component a glucocorticosteroid compound is described. The aqueous suspension contains nanoparticles of a glucocorticosteroid compound and a dispersion stabilizer. The nanoparticles have a mean particle diameter of 300 nm or less and a D90 particle diameter of 450 nm or less. The pharmaceutical compositions containing the aqueous suspension are for parenteral administrations, injections, eye drops or ear drops. More specifically the aqueous suspensions containing glucocorticosteroid nanoparticles are used as an eye drop for treating or preventing inflammatory diseases of the eye or an ear drop for treating or preventing inflammatory diseases of the ear.

Abstract: An automotive folding seat device includes a seat support platform that is mounted on a floor, a cushion storage mechanism that is capable of moving a seat cushion from an in-use position to a storage position, a reclining mechanism that is capable of selectively holding a seat back at a raised position and a dropped-down position, and a coupling mechanism that provides a link between the reclining mechanism and the cushion storage mechanism, wherein the floor has formed thereon an elevated surface and a low surface, which is lower than the elevated surface, the seat support platform is mounted on the elevated surface, and the cushion storage mechanism is arranged so as to be capable of moving the seat cushion from the in-use position, which is higher than the elevated surface, to the storage position, which is close to the low surface.

Abstract: An aqueous suspension preparation that comprises a macrolide antibacterial agent as an active component. The aqueous suspension preparation is characterized by comprising nanoparticles of a macrolide antibacterial agent and a dispersion stabilizer; an aqueous suspension in which the average particle size of nanoparticles is 500 nm or less and the D90 particle size is 1,500 nm or less; a parenterally administered pharmaceutical composition that comprises this aqueous suspension preparation; an injection preparation; and eye drops or ear drops, more specifically, eye drops for the treatment or prevention of inflammatory diseases of the eye or ear drops for the treatment or prevention of inflammatory diseases of the ear.

Abstract: An automotive folding seat device includes a seat support platform that is mounted on a floor, a cushion storage mechanism that is capable of moving a seat cushion from an in-use position to a storage position, a reclining mechanism that is capable of selectively holding a seat back at a raised position and a dropped-down position, and a coupling mechanism that provides a link between the reclining mechanism and the cushion storage mechanism, wherein the floor has formed thereon an elevated surface and a low surface, which is lower than the elevated surface, the seat support platform is mounted on the elevated surface, and the cushion storage mechanism is arranged so as to be capable of moving the seat cushion from the in-use position, which is higher than the elevated surface, to the storage position, which is close to the low surface.